The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
RE: OSTEOPOROSIS AFTER ORCHIECTOMY FOR PROSTATE CANCER
Abstract
PURPOSE: The possibility of increased osteoporosis and osteoporotic fractures following therapeutic orchiectomy in men with prostate cancer was investigated. MATERIALS AND METHODS: A total of 235 men with nonstage A prostate cancer diagnosed between 1983 and 1990 was analyzed for therapeutic orchiectomy, other osteoporotic risk factors and subsequent hospital treatment for osteoporotic fractures. The 17 castrated men alive in 1995 were interviewed, and femoral neck bone mineral density was compared to that of 23 controls of similar age. RESULTS: Risk factors for osteoporosis, including smoking, slender habitus and atrophic testes, were common among men treated with orchiectomy. Of the men in the study cohort 10 had osteoporotic fractures: 8 of 59 treated with and 2 of 176 without orchiectomy (13.6 versus 1.1%, p < 0.001). First fracture cumulative incidence rates 7 years after castration or diagnosis were 28 and 1%, respectively (p < 0.001). Osteoporotic fractures were much more common than pathological fractures or those due to major trauma (1 each). Bone mineral density averaged 0.91, 0.84, 0.79 and 0.66 gm./cm.2 in 9 controls without prostate cancer, 14 men with prostate cancer before orchiectomy, 9 men at 9 to 60 and 8 men at 60 to 115 months after orchiectomy, respectively. Of the 16 men surviving for longer than 60 months after orchiectomy 6 had osteoporotic fractures, as did 5 of 6 and 5 of 7 with a bone mineral density of less than 0.70 gm./cm.2 and less than 75% of normal for age, respectively. CONCLUSIONS: Orchiectomy for prostate cancer is frequently followed by severe osteoporosis, some of which had developed before castration. Appropriate therapy should be identified that does not diminish the antitumorigenic effectiveness of androgen ablation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Walsh, M. P. C. (1986) · Cited by 3,471
Liberman, U. A., Weiss, S. R., Bröll, J., Minne, H. W., Quan, H., Bell, N. H., Rodriguez-Portales, J., Downs, R. W., Dequeker, J., Favus, M., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511303332201 · Cited by 2,288
Khosla, S., Amin, S., & Orwoll, E. (2008) · Endocrine Reviews · doi:10.1210/er.2008-0002 · Cited by 930
Gittes, R. F. (1991) · New England Journal of Medicine · doi:10.1056/nejm199101243240406 · Cited by 738
Risk factors for spinal osteoporosis in men
Seeman, E., Melton, L. J., O'Fallon, W. M., & Riggs, B. L. (1983) · The American Journal of Medicine · doi:10.1016/0002-9343(83)90878-1 · Cited by 659
Testosterone replacement therapy improves mood in hypogonadal men--a clinical research center study
Wang, C. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.10.3578 · Cited by 453
Osteopenia in Men with a History of Delayed Puberty
Finkelstein, J. S., Neer, R. M., Biller, B. M. K., Crawford, J. D., & Klibanski, A. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202273260904 · Cited by 439
ŠTĚPÁN, J. J., LACHMAN, M., ZVĚŘINA, J., PACOVSKÝ, V., & BAYLINK, D. J. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-3-523 · Cited by 424
Osteoporosis in Men with Idiopathic Hypogonadotropic Hypogonadism
FINKELSTEIN, J. S., KLIBANSKI, A., NEER, R. M., GREENSPAN, S. L., ROSENTHAL, D. I., & CROWLEY, W. F. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-3- · Cited by 408
Daniell (1976) · doi:10.1001/archinte.1976.03630030032007 · Cited by 301
Does Hypogonadism Contribute to the Occurrence of a Minimal Trauma Hip Fracture in Elderly Men?
Stanley, H. L., Schmitt, B. P., Poses, R. M., & Deiss, W. P. (1991) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1991.tb02698.x · Cited by 264
Townsend, M. F., Sanders, W. H., Northway, R. O., & Graham, S. D. (1997) · Cancer · doi:10.1002/(sici)1097-0142(19970201)79:3<545::aid-cncr17>3.0.co;2-3 · Cited by 260
BURRIS, A. S., BANKS, S. M., CARTER, C. S., DAVIDSON, J. M., & SHERINS, R. J. (1992) · Journal of Andrology · doi:10.1002/j.1939-4640.1992.tb00319.x · Cited by 259
The Effect of Estrogen Dose on Postmenopausal Bone Loss
Horsman, A., Jones, M., Francis, R., & Nordin, C. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312083092301 · Cited by 214
Kelepouris, N., Harper, K. D., Gannon, F., Kaplan, F. S., & Haddad, J. G. (1995) · Annals of Internal Medicine · doi:10.7326/0003-4819-123-6-199509150-00010 · Cited by 201
Follow-up Prostate Cancer Treatments After Radical Prostatectomy: a Population-Based Study
Lu-Yao, G. L., Potosky, A. L., Albertsen, P. C., Wasson, J. H., Barry, M. J., & Wennberg, J. E. (1996) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/88.3-4.166 · Cited by 196
Bone mineral density in patients with prostatic cancer treated with orchidectomy and with estrogens
Eriksson, S., Eriksson, A., Stege, R., & Carlstr�m, K. (1995) · Calcified Tissue International · doi:10.1007/bf00298427 · Cited by 191
The Effect of a Gonadotropin-Releasing Hormone Agonist Analog (Nafarelin) on Bone Metabolism
JOHANSEN, J. S., RIIS, B. J., HASSAGER, C., MOEN, M., JACOBSON, J., & CHRISTIANSEN, C. (1988) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-67-4-701 · Cited by 189
Testosterone Deficiency As a Risk Factor for Hip Fractures in Men: A Case-Control Study
Jackson, J. A., Riggs, M. W., & Spiekerman, A. M. (1992) · The American Journal of the Medical Sciences · doi:10.1097/00000441-199207000-00003 · Cited by 183
Goldray, D. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.2.288 · Cited by 174
Pathogenesis of Vertebral Crush Fractures in Men
BAILLIE, S. P., DAVISON, C. E., JOHNSON, F. J., & Francis, R. M. (1992) · Age and Ageing · doi:10.1093/ageing/21.2.139 · Cited by 139
Herr, H. W., Kornblith, A. B., & Ofman, U. S. (1993) · Cancer · doi:10.1002/1097-0142(19930201)71:3+<1143::aid-cncr2820711437>3.0.co;2-i · Cited by 134
Meier, D. E., Orwoll, E. S., Keenan, E. J., & Fagerstrom, R. M. (1987) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1987.tb02308.x · Cited by 131
Riis, B. J., Christiansen, C., Johansen, J. S., & Jacobson, J. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-4-920 · Cited by 131
Jønler, M., Madsen, F. A., Rhodes, P. R., Sall, M., Messing, E. M., & Bruskewitz, R. C. (1996) · Urology · doi:10.1016/s0090-4295(96)00216-6 · Cited by 126
Percival, R. C., Urwin, G. H., Harris, S., Yates, A. J. P., Williams, J. L., Beneton, M. N. C., & Kanis, J. A. (1987) · PubMed · Cited by 124
MATTA, W. H. M., Shaw, R. W., Hesp, R., & Katz, D. (1987) · BMJ · doi:10.1136/bmj.294.6586.1523 · Cited by 100
Bone and mineral metabolism in the androgen-resistant (testicular feminized) male rat
Vanderschueren, D., Herck, E. V., Suiker, A. M. H., Visser, W. J., Schot, L. P. C., Chung, K., Lucas, R. S., Einhorn, T. A., & Bouillon, R. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080705 · Cited by 100
Plasma Testosterone Levels in Patients with Prostatic Carcinoma Before and after Treatment
YOUNG, H. H., & Kent, J. R. (1968) · The Journal of Urology · doi:10.1016/s0022-5347(17)62795-2 · Cited by 92
Flutamide-mediated androgen blockade evokes osteopenia in the female rat
Goulding, A., & Gold, E. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080615 · Cited by 76
SCHARLA, S. H., Minne, H. W., Waibel-Treber, S., Schaible, A., Lempert, U. G., Wüster, C. C., LEYENDECKER, G., & Ziegler, R. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-70-4-1055 · Cited by 76
Tomić, R., Bergman, B. O., Bamber, J.-E., et al. (1983) · The Journal of Urology · doi:10.1016/s0022-5347(17)51110-6 · Cited by 74
A Worse Prognosis for Smokers with Prostate Cancer
Daniell, H. (1995) · The Journal of Urology · doi:10.1016/s0022-5347(01)67253-7 · Cited by 72
Analysis of Prognostic Factors in Men with Metastatic Prostate Cancer
Ernst, D. S., Hanson, J., Venner, P. M., & Uro-Oncology Group of Northern Alberta (1991) · The Journal of Urology · doi:10.1016/s0022-5347(17)37797-2 · Cited by 69
Vanderschueren, D., Herck, E. V., Schot, P., Rush, E. B., Einhorn, T. A., Geusens, P., & Bouillon, R. (1993) · Calcified Tissue International · doi:10.1007/bf01351841 · Cited by 64
Prognostic value of serum hormone concentrations in prostatic cancer
Eriksson, A., & Carlström, K. (1988) · The Prostate · doi:10.1002/pros.2990130307 · Cited by 36
The Effects of Orchidectomy on Skeletal Metabolism in Metastatic Prostate Cancer
Clarke, N. W., McClure, J., & George, N. J. R. (1993) · Scandinavian Journal of Urology and Nephrology · doi:10.3109/00365599309182280 · Cited by 36
A Better Prognosis for Obese Men with Prostate Cancer
Daniell, H. (1996) · The Journal of Urology · doi:10.1016/s0022-5347(01)66599-6 · Cited by 35
Osteoporosis occurring in two patients receiving LHRH analogs for carcinoma of the prostate
Collinson, M. P., TYRRELL, C. J., & Hutton, C. (1994) · Calcified Tissue International · doi:10.1007/bf00295959 · Cited by 31
Lukkarinen, O. A., Kontturi, M. J., & Finnish Zoladex Multicentre Study Group (1994) · Scandinavian Journal of Urology and Nephrology · doi:10.3109/00365599409180495 · Cited by 24
“Chemical Castration” for Sex Offenders
Berlin, F. S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704033361420 · Cited by 22
Cited by
Saad, F., Gleason, D. M., Murray, R., Tchekmedyian, S., Venner, P., Lacombe, L., Chin, J. L., Vinholes, J. J., Goas, J. A., & Chen, B. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.19.1458 · Cited by 1,656
Kirby, M., Hirst, C., & Crawford, E. D. (2011) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2011.02799.x · Cited by 861
Vanderschueren, D., Vandenput, L., Boonen, S., Lindberg, M. K., Bouillon, R., & Ohlsson, C. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0003 · Cited by 717
Changes in body composition during androgen deprivation therapy for prostate cancer
Smith, M. R., Finkelstein, J. S., McGovern, F. J., Zietman, A. L., Fallon, M. A., Schoenfeld, D. A., & Kantoff, P. W. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.2.8299 · Cited by 697
Pamidronate to Prevent Bone Loss during Androgen-Deprivation Therapy for Prostate Cancer
Smith, M. R., McGovern, F. J., Zietman, A. L., Fallon, M. A., Hayden, D. L., Schoenfeld, D. A., Kantoff, P. W., & Finkelstein, J. S. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010845 · Cited by 696
Metadata
- Authors
- Krongrad, A., Levis, S., & Roos, B. A.
- Venue
- Journal of Urology
- Published
- 1997-10
- Volume
- 158
- Issue
- 4
- Pages
- 1529-1530
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W1974305754
- Cited by
- 339
- References
- 41
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.